Disc Medicine's stock surged 38% after its experimental drug bitopertin met all primary and secondary endpoints in a pivotal Phase 3 trial for erythropoietic protoporphyria (EPP), a rare disease causing severe pain from sunlight exposure. The drug significantly reduced harmful blood substances and increased patients' pain-free light exposure time. Bitopertin was generally well tolerated, with dizziness as the most common side effect. Disc plans to resubmit its New Drug Application to the FDA by the end of 2026, aiming for regulatory approval by mid-2027, supported by $718 million in cash reserves.
Disc Medicine's recent surge provides context for health sector activity on Pluang as of Oct 19, 2026 21:21 WIB. Among 150 health-sector US stocks, 90 rose and 55 fell today. Notable gainers include Moderna (MRNA) at USD 227.50 with a 4.35% increase and a typical hold time of 59 days, Spyre Therapeutics (SYRE) at USD 83.29 up 4.24% with a 4-day hold, and Citius Pharmaceuticals (CTXR) at USD 0.48 rising 4.13% with a 17-day hold time.
AIBotics has completed the acquisition of NovaCore Labs' assets from PlayJamaica Limited, gaining technology, software, drones, mapping equipment, and customer contracts. This move expands AIBotics' platform in Jamaica and the Caribbean, enhancing AI...
Venture Global is expanding its power business by securing deals with GE Vernova and Baker Hughes to build natural gas-fired power plants for data centers, aiming to meet the high electricity demands of AI systems. The company also plans to grow its ...
Bill Gross, a serial entrepreneur behind over 175 companies, has launched Idealab.ai, a platform using AI to generate and share over 1.2 million business ideas based on real-world problems. The platform aims to lower barriers to entrepreneurship by h...
AIOS Tech Inc. announced an agreement to acquire SmartCore Holdings Limited in an all-stock transaction valued at approximately $100 million. The deal will issue 33.3 million AIOS shares to SmartCore's sellers, who will hold about 80% of AIOS shares ...
The Portnoy Law Firm has launched an investigation into Cardinal Infrastructure Group for possible securities fraud following the company's Q2 2026 financial report. Cardinal revealed a decline in its gross profit margin to 10.8%, down from 13.9% the...
